File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Inarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response

TitleInarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response
Authors
Issue Date2018
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Citation
The American Association for the Study of Liver Diseases (AASLD): The Liver Meeting, San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. 1, Suppl., p. 48A How to Cite?
DescriptionOral Abstract no. 75
Persistent Identifierhttp://hdl.handle.net/10722/275327
ISSN
2019 Impact Factor: 14.679
2015 SCImago Journal Rankings: 4.752

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorElkhashab, M-
dc.contributor.authorChen, CY-
dc.contributor.authorChen, YF-
dc.contributor.authorCoffin, CS-
dc.contributor.authorFung, SK-
dc.contributor.authorGreenbloom, S-
dc.contributor.authorJang, JW-
dc.contributor.authorJeng, WJ-
dc.contributor.authorKim, DJ-
dc.contributor.authorKim, YJ-
dc.contributor.authorKim, W-
dc.contributor.authorLee, KS-
dc.contributor.authorLim, YS-
dc.contributor.authorLiu, CJ-
dc.contributor.authorRamji, A-
dc.contributor.authorIyer, R-
dc.contributor.authorMacfarlane, C-
dc.contributor.authorJackson, K-
dc.contributor.authorLocarnini, S-
dc.contributor.authorAfdhal, NH-
dc.contributor.authorChan, HLY-
dc.contributor.authorACHIEVE STUDY Investigators,-
dc.date.accessioned2019-09-10T02:40:19Z-
dc.date.available2019-09-10T02:40:19Z-
dc.date.issued2018-
dc.identifier.citationThe American Association for the Study of Liver Diseases (AASLD): The Liver Meeting, San Francisco, USA, 9-13 November 2018. Abstracts in Hepatology, 2018, v. 68 n. 1, Suppl., p. 48A-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/275327-
dc.descriptionOral Abstract no. 75-
dc.languageeng-
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/-
dc.relation.ispartofHepatology-
dc.relation.ispartofAASLD (American Association for the Study of Liver Diseases): The Liver Meeting, 2018-
dc.titleInarigivir demonstrates potent dose dependent anti-viral activity in HBV treatment-naive patients: role of HBeAg status and baseline HBsAg in anti-viral response-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.hkuros304556-
dc.identifier.volume68-
dc.identifier.issue1, Suppl.-
dc.identifier.spage48A-
dc.identifier.epage48A-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats